1.
Semin Oncol Nurs
; 25(2): 115-9, 2009 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19411014
RESUMO
OBJECTIVES: To discuss the history, current state, and future directions of umbilical cord blood (UCB) transplantation as it relates to the emerging field of cellular therapies. DATA SOURCES: Research studies, articles, and personal experiences. CONCLUSION: Transplantation using hematopoietic stem cells from UCB is a life-saving option for patients with select oncologic and immunologic diseases, bone marrow failure, hemoglobinopathies, and inborn errors of metabolism.